BMC cancer
Efficacy and safety of anti-VEGF/VEGFR monotherapy and combination with immune checkpoint inhibitors for advanced or metastatic renal cell carcinoma: a network meta-analysis.
Min Duan, Yanjun Liu, Kexin Qiao, Zuojing Li, Dongsheng Zong
Published: 202610.1186/s12885-026-15579-1
No abstract available for this study.